L M Greenberger Selected Research

Raloxifene Hydrochloride (Evista)

10/2001

A new antiestrogen, 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol hydrochloride (ERA-923), inhibits the growth of tamoxifen-sensitive and -resistant tumors and is devoid of uterotropic effects in mice and rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

L M Greenberger Research Topics

Disease

4	Neoplasms (Cancer) 02/2012 - 10/2001
3	Breast Neoplasms (Breast Cancer) 09/2006 - 01/2000
1	Leukemia 02/2012
1	Endometrial Neoplasms (Endometrial Cancer) 10/2001
1	Carcinoma (Carcinomatosis) 10/2001

Drug/Important Bio-Agent (IBA)

2	Antisense OligonucleotidesIBA 02/2012 - 04/2011
2	Messenger RNA (mRNA)IBA 02/2012 - 04/2011
2	Proteins (Proteins, Gene)FDA Link 04/2011 - 01/2000
2	Tamoxifen FDA LinkGeneric 09/2006 - 10/2001
2	2- (4- hydroxyphenyl)- 3- methyl- 1- (4- (2- piperidin- 1- yl- ethoxy)- benzyl)- 1H- indol- 5- olIBA 09/2006 - 10/2001
2	Estrogen Receptor Modulators (Antiestrogen)IBA 09/2006 - 10/2001
1	SurvivinIBA 02/2012
1	Small Interfering RNA (siRNA)IBA 02/2012
1	locked nucleic acidIBA 04/2011
1	TOR Serine-Threonine KinasesIBA 09/2006
1	temsirolimus FDA Link 09/2006
1	Hormones (Hormone)IBA 09/2006
1	Estrogen Receptor alphaIBA 09/2006
1	Estrogens (Estrogen)FDA Link 10/2001
1	Estrogen ReceptorsIBA 10/2001
1	Raloxifene Hydrochloride (Evista)FDA Link 10/2001
1	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2000
1	RacivirIBA 01/2000
1	tryptoquivalineIBA 01/2000

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 02/2012
1	Therapeutics 09/2006